Autres langues Medigen Biotechnology Corp.

Actions

3176

TW0003176004

Cours en clôture Taipei Exchange Autres places de cotation 00:00:00 03/05/2024			Varia. 5j.	Varia. 1 janv.
39,2 ^TWD	+0,26%		+1,42%	-12,50%

29/03	Le ministère de la santé et des affaires sociales approuve le projet de thérapie cellulaire autologue Gamma-Delta T de Medigen Biotechnology Corp. et de l'hôpital Chi Mei	CI
15/03	Medigen Biotechnology Corp. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

The Ministry of Health and Welfare Approves Collaborative Autologous Gamma-Delta T Cell Therapy Project by Medigen Biotechnology Corp. and Chi Mei Hospital	29/03
Taiwan MOHW Approves A New Version of the Collaborative Autologous Natural Killer Cell Therapy Project by Medigen Biotechnology Corp. and Changhua Christian Hospital	26/03
Medigen Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Medigen Biotechnology Corp. Announces Appointment of Chieh-Liang Lin as Chief Scientific Officer	11/03
Medigen Biotechnology Corp. Applies to the Taiwan Food and Drug Administration for Phase I/Ii Clinical Trial Ofallogeneic Natural Killer Cells (Magicell-NK)	29/02
Medigen Biotechnology Corp. Announces That the Ministry of Health and Welfare Has Approved the Collaborative Autologous Gamma-Delta T Cell Therapy Project by the Company and Changhua Christian Hospital	16/02
Medigen Biotechnology Corp. Announces Signing of the Sales Cooperation Agreement for the New Drug OBP-301 in Japan	07/02
The Ministry of Health and Welfare Approves the Collaborative Autologous Gamma-Deltat Cell Therapy Project by Medigen Biotechnology Corp.And Taichung Tzu Chi Hospital	11/01
Medigen Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11/11
Medigen Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23
Medigen Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Medigen Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23
Medigen Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/11/22
Medigen Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/08/22
Medigen Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
Medigen Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	30/03/22
Medigen Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21
Medigen Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	14/08/21
Medigen Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	13/05/21
Medigen Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	29/03/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Medigen Biotechnology Corp.

Actions

3176

TW0003176004

Autres langues

Filtres